Atlas Trials

Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma

Clinical trial NCT06718257 · RECRUITING

Trial details

NCT number
NCT06718257
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Status
RECRUITING
Study type
OBSERVATIONAL
Cholangiocarcinoma
Start date
2024-09-01
Primary completion
2025-03-31
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.